Gilder Gagnon Howe & Co’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-706
Closed -$24K 281
2016
Q1
$24K Hold
706
﹤0.01% 228
2015
Q4
$21K Sell
706
-85,152
-99% -$2.87M ﹤0.01% 239
2015
Q3
$2.71M Sell
85,858
-136,254
-61% -$6.65M 0.04% 156
2015
Q2
$10.7M Sell
222,112
-18,436
-8% -$777K 0.14% 109
2015
Q1
$10.4M Buy
+240,548
New +$8.64M 0.14% 100

Other funds holding PGEN

Gilder Gagnon Howe & Co's PGEN Position: Q2 2016 in Review

Gilder Gagnon Howe & Co sold out of Precigen (PGEN) in Q2 2016, closing a stake of 706 shares — an estimated $24K sold.

Gilder Gagnon Howe & Co first reported a position in PGEN in Q1 2015 and held it in 5 quarters. The position peaked at $10.7M in Q2 2015. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

  • Gilder Gagnon Howe & Co reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 706 Precigen shares in Q2 2016, an estimated $24K.
  • Gilder Gagnon Howe & Co first reported a position in Precigen in Q1 2015 and held it in 5 quarters.
  • Gilder Gagnon Howe & Co's Precigen position peaked at $10.7M in Q2 2015.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2016, filed 1 Aug 2016.